Shufeng Zhou, MD & PhD
Shufeng Zhou, MD & PhD
Professor & Dean, Huaqiao University
Dirección de correo verificada de - Página principal
Citado por
Citado por
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II
SF Zhou
Clinical Pharmacokinetics 48 (12), 761-804, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I
SF Zhou
Clinical Pharmacokinetics 48 (11), 689-723, 2009
Herb-drug interactions
Z Hu, X Yang, PCL Ho, SY Chan, PWS Heng, E Chan, W Duan, HL Koh, ...
Drugs 65 (9), 1239-1282, 2005
Polymorphism of human cytochrome P450 enzymes and its clinical impact
SF Zhou, JP Liu, B Chowbay
Drug Metabolism Reviews 41 (2), 89-295, 2009
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
SF Zhou
Xenobiotica 38 (7-8), 802-832, 2008
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
SF Zhou
Current Drug Metabolism 9 (4), 310-322, 2008
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs
SF Zhou, SY Chan, BC Goh, E Chan, W Duan, M Huang, HL McLeod
Clinical Pharmacokinetics 44 (3), 279-304, 2005
Herbal modulation of P‐glycoprotein
SF Zhou, LY Lim, B Chowbay
Drug Metabolism Reviews 36 (1), 57-104, 2004
Interactions of herbs with cytochrome P450
SF Zhou, Y Gao, W Jiang, M Huang, A Xu, JW Paxton
Drug Metabolism Reviews 35 (1), 35-98, 2003
Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes
JS Bian, QC Yong, TT Pan, ZN Feng, MY Ali, SF Zhou, PK Moore
Journal of Pharmacology and Experimental Therapeutics 316 (2), 670-678, 2006
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development
SF Zhou, LL Wang, YM Di, CC Xue, W Duan, CG Li, Y Li
Current Medicinal Chemistry 15 (20), 1981-2039, 2008
Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring
SF Zhou, CC Xue, XQ Yu, C Li, G Wang
Therapeutic Drug Monitoring 29 (6), 687-710, 2007
Herbal bioactivation: the good, the bad and the ugly
SF Zhou, HL Koh, Y Gao, Z Gong, EJD Lee
Life Sciences 74 (8), 935-968, 2004
New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics
SY Pan, SF Zhou, SH Gao, ZL Yu, SF Zhang, MK Tang, JN Sun, DL Ma, ...
Evidence-Based Complementary and Alternative Medicine 2013, 2013
Effects of Ganopoly® (A ganoderma lucidum polysaccharide extract) on the immune functions in advanced‐stage cancer patients
Y Gao, SF Zhou, W Jiang, M Huang, X Dai
Immunological Investigations 32 (3), 201-215, 2003
Pharmacokinetic interactions of drugs with St John’s wort
SF Zhou, E Chan, SQ Pan, M Huang, EJD Lee
Journal of Psychopharmacology 18 (2), 262-276, 2004
Drug bioactivation covalent binding to target proteins and toxicity relevance
SF Zhou, E Chan, W Duan, M Huang, YZ Chen
Drug Metabolism Reviews 37 (1), 41-213, 2005
Clinical pharmacogenetics and potential application in personalized medicine
SF Zhou, Y Ming Di, E Chan, YM Du, VDW Chow, CC Xue, X Lai, ...
Current Drug Metabolism 9 (8), 738-784, 2008
Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation
LL Wang, Z Zhang, Q Li, R Yang, X Pei, Y Xu, J Wang, SF Zhou, Y Li
Human Reproduction 24 (3), 562-579, 2009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20